- Chart
- Upturn Summary
- Highlights
- About
Amplify Seymour Cannabis ETF (CNBS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: CNBS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit -38.58% | Avg. Invested days 19 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance | ETF Returns Performance |
Key Highlights
Volume (30-day avg) - | Beta 1.06 | 52 Weeks Range 13.96 - 40.80 | Updated Date 06/30/2025 |
52 Weeks Range 13.96 - 40.80 | Updated Date 06/30/2025 |
Upturn AI SWOT
Amplify Seymour Cannabis ETF
ETF Overview
Overview
The Amplify Seymour Cannabis ETF (CNBS) is an actively managed ETF that seeks to provide capital appreciation by investing in companies involved in the cannabis industry. It focuses on businesses that are directly or indirectly engaged in the cultivation, production, distribution, and sale of cannabis and hemp-related products, as well as ancillary businesses that support the cannabis industry. The ETF aims to capture the growth potential of this evolving sector.
Reputation and Reliability
Amplify ETFs is a relatively newer entrant in the ETF space, known for its thematic and actively managed strategies. While not as established as some of the legacy ETF providers, Amplify has built a reputation for offering specialized investment products that cater to niche markets. Their focus on active management aims to leverage expertise to navigate complex sectors.
Management Expertise
The ETF is managed by Amplify ETFs, with the portfolio management responsibilities often attributed to specific individuals or teams within the firm. While detailed individual manager biographies might be proprietary, Amplify's strategy generally relies on a team with experience in identifying emerging trends and managing actively traded portfolios.
Investment Objective
Goal
The primary investment goal of the Amplify Seymour Cannabis ETF is to achieve long-term capital appreciation by investing in a diversified portfolio of companies within the global cannabis and hemp ecosystem.
Investment Approach and Strategy
Strategy: CNBS is an actively managed ETF. It does not track a specific index but rather aims to identify and invest in companies with significant exposure to the cannabis and hemp industries, based on the portfolio manager's research and conviction. The strategy involves identifying companies across various stages of the value chain.
Composition The ETF primarily holds common stocks of companies operating in the cannabis sector. This can include cultivators, processors, distributors, and companies providing ancillary services or products to the cannabis industry. The portfolio is not limited to a specific geography, though it generally focuses on companies operating in markets with developing or established legal frameworks for cannabis.
Market Position
Market Share: As a specialized, actively managed ETF in a niche sector, CNBS typically holds a smaller market share compared to broad-market ETFs. Its market share is concentrated within the cannabis ETF segment.
Total Net Assets (AUM): 69600000
Competitors
Key Competitors
- ETFMG Alternative Harvest ETF (MJ)
- Cannabis ETF (THCX)
- Global X Cannabis ETF (POTX)
Competitive Landscape
The US cannabis ETF market is relatively concentrated, with a few dominant players. CNBS competes in a space characterized by high growth potential but also significant regulatory and market volatility. Its active management strategy is a key differentiator against passively managed ETFs, potentially allowing for more tactical positioning. However, active management also comes with higher expense ratios and the risk of underperformance relative to a benchmark or more passively managed peers. CNBS's advantage lies in its focused approach to the cannabis ecosystem, but it faces challenges from larger, more established ETFs with broader investor bases and potentially lower costs.
Financial Performance
Historical Performance: Historical performance data for CNBS shows significant volatility, which is characteristic of the cannabis sector. Over various periods, the ETF has experienced both substantial gains and losses, reflecting the dynamic and evolving nature of the industry. For instance, performance can be heavily influenced by regulatory news, company-specific developments, and broader economic sentiment towards growth sectors. Specific numerical data for various timeframes (e.g., 1-year, 3-year, 5-year returns) would require real-time data lookup and is subject to change.
Benchmark Comparison: CNBS does not track a specific benchmark index. As an actively managed fund, its performance is evaluated against its own objectives and the performance of its underlying holdings in the cannabis sector. Direct benchmark comparison is less relevant than assessing its alpha generation capability relative to the sector's overall movement.
Expense Ratio: 0.7
Liquidity
Average Trading Volume
The average trading volume for CNBS is moderate, indicating reasonable liquidity for most retail investors, though it may be lower than highly liquid broad-market ETFs.
Bid-Ask Spread
The bid-ask spread for CNBS is typically wider than that of larger, more liquid ETFs, reflecting the specialized nature of its holdings and the associated trading costs.
Market Dynamics
Market Environment Factors
The cannabis ETF market is heavily influenced by evolving legal and regulatory frameworks in the US and globally, shifts in consumer demand, competition from illicit markets, and broader economic conditions that affect investor appetite for high-growth, high-risk sectors. Advancements in cultivation technology and the emergence of new product categories also play a significant role.
Growth Trajectory
The cannabis sector has seen periods of rapid growth followed by consolidation and challenges due to regulatory hurdles. CNBS's growth trajectory is intrinsically linked to the expansion and maturation of the legal cannabis industry. Changes in strategy and holdings are driven by the portfolio manager's assessment of emerging opportunities and risks within the sector, potentially involving shifts in geographic focus or sub-sector allocation.
Moat and Competitive Advantages
Competitive Edge
CNBS's competitive edge stems from its actively managed approach, which allows for dynamic adjustments to capitalize on specific opportunities within the cannabis ecosystem. The fund's management team aims to identify undervalued companies or those poised for significant growth, potentially offering an advantage over passively managed ETFs. Its focused specialization in the cannabis sector allows for deep industry insight and targeted investment. The active strategy also provides flexibility to navigate the regulatory uncertainties inherent in the industry.
Risk Analysis
Volatility
The ETF exhibits high historical volatility, mirroring the inherent risks and speculative nature of the cannabis industry. This means its price can fluctuate significantly over short periods.
Market Risk
Market risk for CNBS is substantial due to its concentration in the cannabis sector, which is subject to significant regulatory, legal, and political uncertainties. These include potential changes in federal and state laws, differing legal frameworks across jurisdictions, and the ongoing challenges of banking and financial services for cannabis-related businesses. Economic downturns can also disproportionately impact growth sectors like cannabis.
Investor Profile
Ideal Investor Profile
The ideal investor for CNBS is one with a high risk tolerance, a belief in the long-term growth potential of the cannabis industry, and an understanding of the significant regulatory and market risks involved. Investors should be prepared for substantial price fluctuations.
Market Risk
CNBS is best suited for long-term investors who are looking for concentrated exposure to the cannabis sector and are comfortable with its inherent volatility. It is less suitable for risk-averse investors or those seeking broad diversification across multiple asset classes. Active traders might also find opportunities due to the sector's volatility, but it requires deep sector knowledge.
Summary
The Amplify Seymour Cannabis ETF (CNBS) is an actively managed fund targeting capital appreciation within the global cannabis and hemp industries. It invests in companies across the value chain, aiming to leverage management expertise to navigate this volatile and evolving sector. While CNBS offers specialized exposure, it faces competition from larger ETFs and carries significant regulatory and market risks. Investors should have a high risk tolerance and a long-term perspective to consider this ETF.
Similar ETFs
Sources and Disclaimers
Data Sources:
- Amplify ETFs Official Website
- Financial Data Providers (e.g., ETF Database, Morningstar, Bloomberg - data is illustrative and subject to real-time changes)
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute investment advice. Investment in ETFs, especially those focused on niche and volatile sectors like cannabis, carries significant risk, including the potential loss of principal. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Amplify Seymour Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Under normal market conditions, the fund seeks to achieve its investment objective by investing in the securities of U.S. companies engaged in cannabis and hemp-related activities selected by the fund"s investment adviser, Amplify Investments LL. Pursuant to this strategy, it will invest at least 80% of its net assets (plus borrowings for investment purposes) in the securities of U.S. companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem and in derivatives that have economic characteristics similar to such securities. The fund is non-diversified.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

